Search Results - "Quiros-Roldan E"

Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study.

Authors: Torti, C Quiros-Roldan, E Scudeller, L et al.

Source: HIV Medicine. Jul2003, Vol. 4 Issue 3, p263-270. 8p.

Lymphocyte homeostasis is maintained in perinatally HIV-infected patients after three decades of life.

Authors: Paghera, S. Quiros-Roldan, E. Sottini, A. et al.

Source: Immunity & Ageing. 10/13/2019, Vol. 16 Issue 1, pN.PAG-N.PAG. 1p.

Peripheral loss of regulatory T cells and polyautoimmunity in an HIV-infected patient.

Authors: Quiros-Roldan, E. Zanini, B. Ferraresi, A. et al.

Source: International Journal of STD & AIDS. 11/15/2018, Vol. 29 Issue 13, p1345-1347. 3p. 1 Graph.

First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006).

Authors: Carosi, G. Quiros-Roldan, E. Torti, C. et al.

Source: Infection. Jun2007, Vol. 35 Issue 3, p134-142. 9p. 4 Charts.

Risk factors for myocardial infarction in HIV-positive patients.

Authors: Quiros-Roldan, E. Torti, C. Tinelli, C. et al.

Source: International Journal of STD & AIDS. Jan2005, Vol. 16 Issue 1, p14-18. 5p. 2 Charts.

Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patients.

Authors: Torti C Quiros-Roldan E Tirelli V et al.

Source: AIDS Patient Care & STDs. Nov2004, Vol. 18 Issue 11, p629-634. 6p.

URL: 15179218

Lopinavir Plasma Levels in Salvage Regimes by a Population of Highly Active Antiretroviral TherapyTreated HIV-1–Positive Patients.

Authors: Torti, C. Quiros-Roldan, E. Tirelli, V. et al.

Source: AIDS Patient Care & STDs. Nov2004, Vol. 18 Issue 11, p629-634. 6p.

Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients.

Authors: Torti C Quiros-Roldan E Keulen W et al.

Source: Journal of Infectious Diseases. 7/15/2003, Vol. 188 Issue 2, p194-201. 8p.

URL: 10427471

This result is not displayed to guests.
Login for full access.

Analysis of regulatory T-cells and of their naïve and memory-like subsets in long-term treated aviremic HIV+ patients and untreated viremic patients.

Authors: Quiros-Roldan, E Serana, F Chiarini, M et al.

Source: Journal of the International AIDS Society. Nov2012 Supplement S4, Vol. 15, p1-1. 1p.

Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort.

Authors: d'Arminio Monforte, Antonella Tavelli, Alessandro Rossotti, Roberto et al.

Source: Liver International. Oct2023, Vol. 43 Issue 10, p2130-2141. 12p. 1 Diagram, 5 Charts.

Potential role of SEN virus on liver enzyme abnormalities in patients positive for hepatitis C virus with or without HIV infection.

Authors: Quiros-Roldan, E. Moretti, F. Torti, C. et al.

Source: European Journal of Clinical Microbiology & Infectious Diseases. Jun2005, Vol. 24 Issue 6, p436-437. 2p.

HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital.

Authors: Quiros-Roldan E Moretti F Torti C et al.

Source: Infection. Jun2003, Vol. 31 Issue 3, p172-173. 2p.

Polymorphic immune restoration syndrome after effective HAART.

Authors: Quiros-Roldan, E. Torti, C. Casari, S. et al.

Source: Sexually Transmitted Infections. Apr2003, Vol. 79 Issue 2, p172. 2p. 1 Graph.

Evidence of HIV-2 Infection in Northern Italy.

Authors: Quiros-Roldan, E. Castelli, F. Pan, A. et al.

Source: Infection. Dec2001, Vol. 29 Issue 6, p362-363. 2p.

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort.

Authors: Taramasso, L Fabbiani, M Nozza, S et al.

Source: HIV Medicine. Sep2020, Vol. 21 Issue 8, p523-535. 13p.

Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort.

Authors: Postorino, M. C. Prosperi, M. Quiros-Roldan, E. et al.

Source: Clinical Microbiology & Infection. Apr2015, Vol. 21 Issue 4, pe1-e9. 9p.

Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort.

Authors: Cingolani, A Zona, S Girardi, E et al.

Source: HIV Medicine. Aug2015, Vol. 16 Issue 7, p412-420. 9p.

Incidence of AIDS-defining cancers and virus-related and non-virus-related non- AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy, 1999-2009.

Authors: Calabresi, A Ferraresi, A Festa, A et al.

Source: HIV Medicine. Sep2013, Vol. 14 Issue 8, p481-490. 10p.

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.

Authors: Torti, C. Prosperi, M. Motta, D. et al.

Source: Clinical Microbiology & Infection. May2012, Vol. 18 Issue 5, p449-458. 10p.